Boehringer Ingelheim Singapore Pte. Ltd. (Singapore)

Boehringer Ingelheim Singapore Pte. Ltd. is the Singapore subsidiary of Boehringer Ingelheim, a Germany-headquartered global pharmaceutical company specializing in human and animal health. The company is engaged in the marketing, distribution, and regional coordination of prescription medicines, biopharmaceutical products, and animal health solutions. Its human pharmaceutical portfolio covers therapeutic areas such as respiratory diseases, cardiovascular conditions, oncology, metabolic disorders, and immunology. In the animal health segment, it supplies vaccines, parasiticides, and livestock health products. The Singapore entity supports regulatory compliance, medical affairs coordination, marketing strategy, and supply chain operations across Southeast Asia. Operating within Singapore's advanced healthcare ecosystem, Boehringer Ingelheim Singapore positions itself as part of a research-driven pharmaceutical group focused on innovation, therapeutic advancement, and long-term healthcare solutions.